The ultimate goal of medical research is to improve the quality of life of patients. Movement disorders, such as Parkinson's disease, multiple system atrophy, Huntington disease, ataxia, etc, are clinical syndromes with either an excess of movement or a paucity of voluntary and involuntary movements, that are complex conditions impacting all components of patients' health-related quality of life.
This workshop aims to identify unmet clinical needs of patients with movement disorders, and potential solutions or therapies to advance the field, so as to provide optimal clinical practice and care for patients with movement disorders. This workshop will invite distinguished experts in the field, provide invaluable networking opportunities and inspiring discussions on the current hot topics of movement disorders, so as to advance the education and research on movement disorders in China.
We are pleased to invite you to join us for the 2022 Tiantan Symposium for Movement Disorders of “Tackle the Unmet Clinical Needs” & China-America International Forum for Brain Science on July 9 to achieve the aims of the program: Exchange, Comprehend, and Advance
 
Chairman: Xiang Gao, Yong-Jun Wang
Organizers: Yue Huang, Ning Li, Irene Litvan
Host Organizations: China Science and Technology Exchange Center; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University; China Association of Gerontology and Geriatrics
Supported By: International Parkinson and Movement Disorder Society (MDS); National Natural Science Foundation of China (NSFC. ID 82071417)
Free registration
Participating via https://wx.vzan.com/live/tvchat-32902173?v=1656812024434  

Identify Unmet Clinical Needs in Movement Disorders
Beijing Time	Title	Speakers	Chairs
8:00-8:55	Opening	Xiang Gao, China Science and Technology Exchange Center，Beijing, China Yong-Jun Wang, Beijing Tiantan Hospital, Capital Medical University, China	Cheng Wu, China Science and Technology Exchange Center，Beijing, China
	Effective neuromodulation for movement disorders	Mu-Ming Poo, Institute of Neuroscience, Chinese Academy of Sciences, Shanghai, China	Li Wei Zhang, Beijing Tiantan Hospital, Capital Medical University, China
	The need to understand why therapeutic trials fail in patients with atypical parkinsonian disorders	Irene Litvan, UC San Diego Health, USA; MDS representative
8:55-9:20	The needs to classify different subtypes of Parkinson’s disease	Biao Chen, Xuan Wu Hospital, Capital Medical University, Beijing.	Wei-Dong Yue, Si-Chuan Provincial People Hospital, Chengdu
9:20-9:45	The needs to identify specific non-motor symptoms across movement disorders	Wei Zhang, Neurology Department, Beijing Tiantan Hospital
9:45-9:55	Q&A
9:55-10:20	Update in the management of atypical parkinsonism	Tao Xie, Neurology Department, The University of Chicago, USA	Qi Shi, China Center for Disease Control and Prevention, Beijing
10:20-10:45	Conformational diversity of pathological proteins: Input from the intracellular environment	Chao Peng, University of California, Los Angeles, USA
10:45-10:55	Q&A
10:55-11:20	The need to understand how the brain-spinal motor system works	Martyn Goulding, Molecular Neurobiology Laboratory, The Salk Institute, La Jolla, CA, USA	Martin Meyer, The Lundbeck Foundation, Denmark
11:20-11:30	Q&A

 

Lunch Workshop – Huntington Disease Session
Time	Title	Speakers	Chair
11:30-11:55	Clinical characters and standardized management of Huntington Disease	Hui-Fang Shang, Neurology Department, West China Hospital, Sichuan University, China	Jean Marc Burgunder, University of Bern, Switzerland, MDS faculty member
11:55-12:20	New horizons in treatment and management of Huntington's Disease	Samuel A Frank, BIDMC Department of Neurology, Boston, USA.
12:20-12:45	A new class of VMAT-2 inhibitors for Huntington's Disease and tardive dyskinesia	Xin-Hua Wan, Peking Union Medical College Hospital, China
12:45-13:10	Clinical phenotypes of Huntington’s disease and related factors	Zhi-Ying Wu, Neurology Department, 2nd Hospital, Zhe Jiang University
13:10-13:20	Panel Discussion

 

Solutions to those unmet needs in movement disorders
Time	Title	Speakers	Chairs
Clinical Assessments
13:20-13:40	Non-motor symptoms in movement disorders and Movement Disorder Society (MDS) rating scales	Zi-Xuan Yang, Psychiatrics Department, Central Adelaide Local Health Network, SA Health, Australia	Runqi Wangqin, Neurology Department, Medical Center, Duke University, USA
13:40-14:00	Clinical experiences about video-based assessments in movement disorders	Jean Marc Burgunder, University of Bern, Switzerland
14:00-14:10	Q&A
Biomarkers
14:10-14:30	Blood biomarkers for movement disorders	Zhong Pei, 1st Hospital, Sun Yat-Sen University, Guangzhou	Bo-Yan Fang, Beijing Kang-Fu Hospital, CMU, Beijing
14:30-14:50	Neuroimaging mimics in parkinsonian disorders	Tao Wu, Beijing Tiantan Hospital, Capital Medical University
15:00-15:10	Q&A
Definitive Diagnosis
15:10-15:30	Neuropathology of Parkinson’s disease	Jia-Yi Li, Lund University, Sweden & Institute of Health Science, China Medical University	Gang Wang, Shanghai Ruijin Hospital, Shanghai JiaoTong University, Shanghai, China
15:30-15:50	Neuropathological comparison of parkinsonian disorders with Huntington’s Disease	Yue Huang, Beijing Tiantan Hospital, Capital Medical University, China
15:50-16:00	Q&A
Treatment Options
16:00-16:20	Traditional Chinese medicine for the treatment of movement disorders	Xue-Song Zhao, Beijing Tiantan Hospital, Capital Medical University, China	Shao-Shi Wang, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai
16:20-16:40	DBS therapy for movement disorders	Jian-Guo Zhang, Beijing Tiantan Hospital, Capital Medical University, China
16:40-16:50	Q&A
16:50-17:00	Summary   -  Yue Huang, Beijing Tiantan Hospital, Capital Medical University, China